Healthcare101

  Metabolism Assays Market in terms of revenue was estimated to be worth $1.4 billion in 2023 and is poised to reach $2.1 billion by 2028, growing at a CAGR of 7.8% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rising initiatives by government to promote metabolic & disease research, innovation in metabolism assays technology by integrating with wearable devices, increase in prevalence of metabolic disorders such as diabetes and obesity, and adoption of metabolism assays by fitness and sports industries. ​ Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=135163479 Browse in-depth TOC on "Metabolism Assays Market" 126 - Tables 38 - Figures 192 – Pages Assay Kits and reagents segment is expected to account for the larger share in 2022. The metabolism assay market, by product, has been segmented into instruments & analyzers and assay kits & reagents. In 2022...

  Metabolism Assays Market in terms of revenue was estimated to be worth $1.4 billion in 2023 and is poised to reach $2.1 billion by 2028, growing at a CAGR of 7.8% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rising initiatives by government to promote metabolic & disease research, innovation in metabolism assays technology by integrating with wearable devices, increase in prevalence of metabolic disorders such as diabetes and obesity, and adoption of metabolism assays by fitness and sports industries. Metabolism Assays Market Trends Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=135163479 Assay Kits and reagents segment is expected to account for the larger share in 2022. The metabolism assay market, by product, has been segmented into instruments & analyzers and assay kits & reagents. In 2022, the assay kits & reagents dominated the products mar...

  Wearable Injectors Market in terms of revenue was estimated to be worth $8.4 billion in 2023 and is poised to reach $15.1 billion by 2029, growing at a CAGR of 10.3% from 2023 to 2029 according to a new report by MarketsandMarkets™. Attractive Opportunities in Wearable injectors market Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=100771004 Browse in-depth TOC on "Wearable Injectors Market" 150 - Tables 40 - Figures 320 – Pages "On Body injectors segment accounted for the largest share during the forecast period." Precise dosing capabilities and extended wear times ensure consistent medication delivery, minimizing missed doses and amplifying treatment efficacy. This translates to a more harmonious clinical outcome, particularlyfor chronic conditions where adherence is crucial. On-body injectors liberate patients from the confines of clinical settings and syringes, enabling self-administration at home or on th...

  Blood Screening Market in terms of revenue was estimated to be worth $2.4 billion in 2023 and is poised to reach $3.4 billion by 2028, growing at a CAGR of 7.2% from 2023 to 2028 according to a new report by MarketsandMarkets™. Growth in this market is mainly driven by the growing requirement for donated blood, the rising number of blood donations around the world, and the ever-increasing infectious diseases. However, operational barriers and the high cost of Blood screening instruments is likely to hamper the growth of blood screening market. Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267747042 Browse in-depth TOC on "Blood Screening Market" 189 - Tables 45 - Figures 220 – Pages The Reagents & Kits segment is expected to account for the largest share in 2022. Based on product, the blood screening market is segmented into reagents & kits, instruments, and software & services. Increase in demand and contin...

 The size of global prefilled syringes market in terms of revenue was estimated to be worth $5.6 billion in 2020 and is poised to reach $8.6 billion by 2025, growing at a CAGR of 9.0% from 2020 to 2025. The research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=16618331 Increasing adoption of self-administered injectable drugs is expected to result in the segment occupying the majority of the industry share The conventional Prefilled Syringes Market is estimated to have the largest market share by value. Growth of this segment can be attributed to the the advantages offered, such as safe administration, ease of use for both healthcare professionals and end users, reduced risk of contamination of the product, less waste of costly API, ease of manufacturing, improved dosing accuracy, and enh...

  Liquid Biopsy Market in terms of revenue was estimated to be worth $6.4 billion in 2024 and is poised to reach $11.3 billion by 2029, growing at a CAGR of 11.9% from 2024 to 2029 according to a new report by MarketsandMarkets™. Liquid Biopsy Market Trends Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=13966350 Browse in-depth TOC on "Liquid Biopsy Market" 406 - Tables 56 - Figures 343 - Pages North America is the largest regional market for liquid biopsy market. The market for liquid biopsy has been divided into six key geographical regions, namely North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. In 2023, North America held the predominant portion of the liquid biopsy market. The region boasts a well-developed healthcare infrastructure, including advanced diagnostic facilities, specialized oncology centers, and a skilled workforce. This infrastructure supports the inte...

 The Global Bone Growth Stimulator Market in terms of revenue was estimated to be worth $1.4 billion in 2022 and is poised to reach $1.8 billion by 2027, growing at a CAGR of 5.9% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growing demand for bone growth stimulators in spinal fusion surgeries, delayed union and nonunion bone fracture applications, and the increasing demand for bone growth stimulator devices are the major driving factors of this market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82341383 Market Dynamics Market Drivers Growing patient preference for noninvasive and minimally invasive surgical treatments Increasing target patient population Rising number of sports and accident-related orthopedic i...